SETH PERLMAN: Open Payments
NPI 1083883896 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$636 in 5 payments from 4 companies in 2025. Trend: 2023 $106 · 2024 $24,143 · 2025 $636
Food & beverage: $636
| Company | Payments | Amount |
|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | 1 | $273 |
| Sarepta Therapeutics, Inc. | 2 | $191 |
| Biogen, Inc. | 1 | $146 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
Products named: AGAMREE, QALSODY, Elevidys.
Industry payments across WA — which companies pay providers there.
